-
France’s Assurance Maladie pushes to ban smoking for young people
Health agency seeks to follow UK example in creating a ‘tobacco-free generation’
-
European airports at ‘critical point’ due to EES, warns trade body
Five-hour queues reported as calls for EES suspensions grow
-
Best mosquito spray in France named by consumer experts
Consumer magazine ranks top repellents as tiger mosquito season continues
Cutback on medicine brands
Patients who refuse a generic medicine in place of a branded one from January 2020 will only be reimbursed based on the price of the generic, according to next year’s social security budget bill.
The rule will apply unless there is a medical justification for it to be waived, for example, if the generic contains an ingredient to which the patient is allergic. Generics cost 40% less on average and the government says money saved can be put to better use, such as for buying innovative medicines to treat childhood cancers. Currently, the only penalty for refusing a generic is you must pay upfront for it and thus do not obtain le tiers payant.
